ZROYPU...nice find in publication citing:
"Results, when completed, will be submitted for publication. Data generated to date supported a federal grant application filed last week by RBL, the testing laboratory, in collaboration with IPIX seeking funds to finance studies evaluating Brilacidin as a pan-coronavirus therapeutic."
1. Identifies to whom grant submitted: FEDERAL grant application (not private)
2. Identifies purpose: finance STUDIES of B as a "pan-coronavirus therapeutic" pointing to...Phase II/III-Human Trials
PS...it also points out the GARBAGE companies and their alleged "IP" NOT INDEPENDENTLY VERIFIED, to whom Fed Grants were given...now being revoked when BS claims are discovered...MORE TO COME...good for IPIX/Brilacidin